These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

335 related articles for article (PubMed ID: 16871873)

  • 1. Immunogene therapy as a treatment for malignant brain tumors in young mice.
    Glick RP; Lichtor T; Lin H; Tarlock K; Cohen EP
    J Neurosurg; 2006 Jul; 105(1 Suppl):65-70. PubMed ID: 16871873
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Application of interleukin-2-secreting syngeneic/allogeneic fibroblasts in the treatment of primary and metastatic brain tumors.
    Lichtor T; Glick RP; Tarlock K; Moffett S; Mouw E; Cohen EP
    Cancer Gene Ther; 2002 May; 9(5):464-9. PubMed ID: 11961669
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunogene therapy with interleukin-2-secreting fibroblasts for intracerebrally metastasizing breast cancer in mice.
    Deshmukh P; Glick RP; Lichtor T; Moser R; Cohen EP
    J Neurosurg; 2001 Feb; 94(2):287-92. PubMed ID: 11213967
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment with allogeneic interleukin-2 secreting fibroblasts protects against the development of malignant brain tumors.
    Glick RP; Lichtor T; Panchal R; Mahendra A; Cohen EP
    J Neurooncol; 2003; 64(1-2):139-46. PubMed ID: 12952294
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intratumoral injection of IL-secreting syngeneic/allogeneic fibroblasts transfected with DNA from breast cancer cells prolongs the survival of mice with intracerebral breast cancer.
    Lichtor T; Glick RP; Lin H; O-Sullivan I; Cohen EP
    Cancer Gene Ther; 2005 Aug; 12(8):708-14. PubMed ID: 15803143
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prolongation of survival of mice with glioma treated with semiallogeneic fibroblasts secreting interleukin-2.
    Glick RP; Lichtor T; de Zoeten E; Deshmukh P; Cohen EP
    Neurosurgery; 1999 Oct; 45(4):867-74. PubMed ID: 10515482
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prolonged survival of mice with established intracerebral glioma receiving combined treatment with peroxisome proliferator-activated receptor-gamma thiazolidinedione agonists and interleukin-2-secreting syngeneic/allogeneic fibroblasts.
    Spagnolo A; Glick RP; Lin H; Cohen EP; Feinstein DL; Lichtor T
    J Neurosurg; 2007 Feb; 106(2):299-305. PubMed ID: 17410715
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Regression of orthotopic brain tumors by cytokine-assisted tumor vaccines primed in the brain.
    Tseng SH; Hsieh CL; Lin SM; Hwang LH
    Cancer Gene Ther; 1999; 6(4):302-12. PubMed ID: 10419048
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intracerebral versus subcutaneous immunization with allogeneic fibroblasts genetically engineered to secrete interleukin-2 in the treatment of central nervous system glioma and melanoma.
    Glick RP; Lichtor T; Mogharbel A; Taylor CA; Cohen EP
    Neurosurgery; 1997 Oct; 41(4):898-906; discussion 906-7. PubMed ID: 9316052
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Therapeutic vaccination against malignant gliomas based on allorecognition and syngeneic tumor antigens: proof of principle in two strains of rat.
    Stathopoulos A; Samuelson C; Milbouw G; Hermanne JP; Schijns VE; Chen TC
    Vaccine; 2008 Mar; 26(14):1764-72. PubMed ID: 18336964
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cytokine immuno-gene therapy for treatment of brain tumors.
    Lichtor T; Glick RP
    J Neurooncol; 2003 Dec; 65(3):247-59. PubMed ID: 14682375
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Autophagic cell death of malignant glioma cells induced by a conditionally replicating adenovirus.
    Ito H; Aoki H; Kühnel F; Kondo Y; Kubicka S; Wirth T; Iwado E; Iwamaru A; Fujiwara K; Hess KR; Lang FF; Sawaya R; Kondo S
    J Natl Cancer Inst; 2006 May; 98(9):625-36. PubMed ID: 16670388
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The combination of ionizing radiation and peripheral vaccination produces long-term survival of mice bearing established invasive GL261 gliomas.
    Newcomb EW; Demaria S; Lukyanov Y; Shao Y; Schnee T; Kawashima N; Lan L; Dewyngaert JK; Zagzag D; McBride WH; Formenti SC
    Clin Cancer Res; 2006 Aug; 12(15):4730-7. PubMed ID: 16899624
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Eradication of rat malignant gliomas by retroviral-mediated, in vivo delivery of the interleukin 4 gene.
    Benedetti S; Bruzzone MG; Pollo B; DiMeco F; Magrassi L; Pirola B; Cirenei N; Colombo MP; Finocchiaro G
    Cancer Res; 1999 Feb; 59(3):645-52. PubMed ID: 9973213
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cancer immunotherapy of established tumors with IL-12. Effective delivery by genetically engineered fibroblasts.
    Zitvogel L; Tahara H; Robbins PD; Storkus WJ; Clarke MR; Nalesnik MA; Lotze MT
    J Immunol; 1995 Aug; 155(3):1393-403. PubMed ID: 7636204
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interleukin-23-expressing bone marrow-derived neural stem-like cells exhibit antitumor activity against intracranial glioma.
    Yuan X; Hu J; Belladonna ML; Black KL; Yu JS
    Cancer Res; 2006 Mar; 66(5):2630-8. PubMed ID: 16510582
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The use of interleukin 12-secreting neural stem cells for the treatment of intracranial glioma.
    Ehtesham M; Kabos P; Kabosova A; Neuman T; Black KL; Yu JS
    Cancer Res; 2002 Oct; 62(20):5657-63. PubMed ID: 12384520
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment of glioma by engineered interleukin 4-secreting cells.
    Yu JS; Wei MX; Chiocca EA; Martuza RL; Tepper RI
    Cancer Res; 1993 Jul; 53(13):3125-8. PubMed ID: 8319220
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Human bone marrow-derived mesenchymal stem cells in the treatment of gliomas.
    Nakamizo A; Marini F; Amano T; Khan A; Studeny M; Gumin J; Chen J; Hentschel S; Vecil G; Dembinski J; Andreeff M; Lang FF
    Cancer Res; 2005 Apr; 65(8):3307-18. PubMed ID: 15833864
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antitumor treatment using interleukin- 12-secreting marrow stromal cells in an invasive glioma model.
    Hong X; Miller C; Savant-Bhonsale S; Kalkanis SN
    Neurosurgery; 2009 Jun; 64(6):1139-46; discussion 1146-7. PubMed ID: 19487894
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.